These upcoming presentations underscore the breadth and versatility of our ACT-UP1 platform,” said Xuehai Liang, Ph.D., Chief Executive Officer of Arnatar Therapeutics. “By demonstrating the ability ...

Scientists have achieved a groundbreaking advancement in preclinical testing by growing mini human livers, known as organoids ...

Echinacea tea may boost immunity and ease cold symptoms because of its powerful antioxidants. However, current research is ...

ORLANDO, FLORIDA / ACCESS Newswire / October 17, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and BioVie, Inc. (Nasdaq:BIVI) on the RedChip Small Stocks, Big ...

This study addresses an important question in liver biology: how zonal hepatocytes balance survival and proliferation following injury; using spatial transcriptomics, mechanistic perturbations, and ...

A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...

Abstract: A secure and privacy-preserving implementation of a robust model predictive controller (RMPC) for polytopic uncertain systems using Paillier encryption is presented. The Paillier encryption ...

A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can ...

Abstract: The increasing use of Artificial Intelligence (AI) in daily life has introduced substantial issues in protecting user privacy, particularly for young digital citizens. This study examines ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

Liver cancer is one of the world's deadliest malignancies, ranking as the third leading cause of cancer-related death.